News Press Releases Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer Oct 02, 2024 Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider May 06, 2024 Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors Feb 08, 2024 Learn More Upcoming Events Interim Report Working Table for the Internationalisation of Biotechnology Industries Oct 16, 2024 at 11:00 AM CEST Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective Oct 25, 2024 Learn More Learn More Corporate Information More information is coming soon. Financial Metrics Price Change Day High Day Low Volume Oct 15, 2024 5:45 PM EDT Stock Chart Minimum 15 minutes delayed. Source: Learn More
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider May 06, 2024
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors Feb 08, 2024
Interim Report Working Table for the Internationalisation of Biotechnology Industries Oct 16, 2024 at 11:00 AM CEST
Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective Oct 25, 2024